Insulin-like growth factors in patients with ovarian tumors (results of own research)
- 作者: Knyazev R1, Kuznetsov V2, Bokin I1, Barinov V2, Kushlinskiy N2, Poddubnaya I1,2
-
隶属关系:
- Russian Medical Academy of Postgraduate Education of the Ministry of Health of the Russian Federation
- N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation
- 期: 卷 18, 编号 1 (2016)
- 页面: 67-74
- 栏目: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/27055
- ID: 27055
如何引用文章
全文:
详细
作者简介
R Knyazev
Russian Medical Academy of Postgraduate Education of the Ministry of Health of the Russian Federation
Email: sluwba@mail.ru
аспирант каф. онкологии ГБОУ ДПО РМАПО 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
V Kuznetsov
N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federationд-р мед. наук, проф., зав. отд-нием гинекологии ФГБУ РОНЦ им. Н.Н.Блохина 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23
I Bokin
Russian Medical Academy of Postgraduate Education of the Ministry of Health of the Russian Federationканд. мед. наук, ассистент каф. онкологии ГБОУ ДПО РМАПО 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
V Barinov
N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federationд-р мед. наук, проф., вед. науч. сотр. отд-ния гинекологии ФГБУ РОНЦ им. Н.Н. Блохина 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23
N Kushlinskiy
N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federationчл.-кор. РАН, д-р мед. наук, проф., зав. лаб. клинической биохимии ФГБУ РОНЦ им. Н.Н.Блохина 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23
I Poddubnaya
Russian Medical Academy of Postgraduate Education of the Ministry of Health of the Russian Federation; N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federationчл.-кор. РАН, д-р мед. наук, проф., зав. каф. онкологии ГБОУ ДПО РМАПО, ФГБУ РОНЦ им. Н.Н.Блохина 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
参考
- King E.R, Wong K.K. Insulin - like growth factor: current concepts and new developments in cancer therapy. Recent Patents Anti - cancer Drug Dis 2012; 7 (1): 14.
- Bruchim I, Sarfstein R, Werner H. The IGF hormonal network in endometrial cancer: functions, regulation, and targeting approaches. Front Endocrin 2014; 5.
- Ma J et al. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells. J Surg Res 2010; 160 (1): 90-101.
- Mairet-Coello G, Tury A, DiCicco-Bloom E. Insulin - like growth factor-1 promotes G1/S cell cycle progression through bidirectional regulation of cyclins and cyclin - dependent kinase inhibitors via the phosphatidylinositol 3-kinase/Akt pathway in developing rat cerebral cortex. J Neurosci 2009; 29 (3): 775-88.
- Rinaldi S et al. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta - analysis of prospective studies. Int J Cancer 2010; 126 (7): 1702-15.
- Cao Y et al. Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer. Int J Cancer 2015; 136 (10): 2418-26.
- Hormones T.E, Group B.C.C. Insulin - like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 2010; 11 (6): 530-42.
- Бочкарева Н.В., Кондакова И.В., Коломиец Л.А. и др. Инсулиноподобные факторы роста и связывающие их белки в патогенезе рака эндометрия. Сиб. онкол. журн. 2008; 3: 27.
- Flannery C.A et al. SAT-0017: Differential Expression of IR-a, IR-B and IGF-1R in Endometrium Reflects Physiology during the Menstrual Cycle and Demonstrates a Distinct Expression Signature in Endometrial Adenocarcinoma. 2014.
- Дигаева М.А. Предикторы эпителиальных опухолей яичников, их роль в патогенезе, диагностике, тактике выбора объема оперативного лечения и прогнозе. Автореф. дис. … д - ра мед. наук. М., 2011.
- An Y et al. Local expression of insulin - like growth factor - I, insulin - like growth factor - I receptor, and estrogen receptor alpha in ovarian cancer. Oncol Res Treat 2009; 32 (11): 638-44.
- Brokaw J et al. IGF-I in epithelial ovarian cancer and its role in disease progression. Growth Factors 2007; 25 (5): 346-54.
- Lu L et al. The relationship of insulin - like growth factor-II, insulin - like growth factor binding protein-3, and estrogen receptor - alpha expression to disease progression in epithelial ovarian cancer. Clin Cancer Res 2006; 12 (4): 1208-14.
- Sayer R.A et al. High insulin - like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer. Gynecol Oncol 2005; 96 (2): 355-61.
- Spentzos D et al. IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer. Endocrine - related Cancer 2007; 14 (3): 781-90.
- Ose J et al. Insulin - like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort. Br J Cancer 2015; 112 (1): 162-6.
- Pollak M. Insulin and insulin - like growth factor signalling in neoplasia. Nat Rev Cancer 2008; 8 (12): 915-28.
- Mikami K et al. Prostate cancer risk in relation to insulin - like growth factor (IGF)-I and IGF-binding protein-3: A nested case - control study in large scale cohort study in Japan. Asian Pac J Cancer Prevention: APJCP 2009; 10: 57-61.
- Sakauchi F et al. Serum Insulin - like Growth Factors I and II, Insulin - like Growth Factor Binding Protein-3 and Risk of Breast Cancer in the JACC Study. Asian Pac J Cancer Prevent 2009; 10: 51-5.
- Suzuki S et al. Insulin - like Growth Factor (IGF)-I, IGF-II, IGF Binding Protein-3, and Risk of Colorectal Cancer: a Nested Case - control Study in the JACC Study. Age 2009; 64 (8.1): 64.9-8.3.
- Tas F et al. Clinical significance of serum insulin - like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer. Tumor Biology 2014; 35 (4): 3125-32.
- Huang Y.F et al. Circulating IGF system and treatment outcome in epithelial ovarian cancer. Endocrine - related Cancer 2014; 21 (2): 217-29.